DK0754058T3 - Sårheling - Google Patents
SårhelingInfo
- Publication number
- DK0754058T3 DK0754058T3 DK95913237T DK95913237T DK0754058T3 DK 0754058 T3 DK0754058 T3 DK 0754058T3 DK 95913237 T DK95913237 T DK 95913237T DK 95913237 T DK95913237 T DK 95913237T DK 0754058 T3 DK0754058 T3 DK 0754058T3
- Authority
- DK
- Denmark
- Prior art keywords
- wound healing
- beta
- growth factor
- agent
- tgf
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/22—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against growth factors ; against growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Hematology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Diabetes (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Materials For Medical Uses (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB9406154A GB2288118A (en) | 1994-03-29 | 1994-03-29 | Wound healing composition |
GBGB9424898.6A GB9424898D0 (en) | 1994-12-09 | 1994-12-09 | Wound healing |
PCT/GB1995/000704 WO1995026203A1 (en) | 1994-03-29 | 1995-03-29 | Wound healing |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0754058T3 true DK0754058T3 (da) | 2000-02-07 |
Family
ID=26304595
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK95913237T DK0754058T3 (da) | 1994-03-29 | 1995-03-29 | Sårheling |
DK99201184T DK0968723T3 (da) | 1994-03-29 | 1995-03-29 | Sårheling eller helbredelse af fibrotiske lidelser ved anvendelse af mindst ét middel mod en vækstfaktor |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK99201184T DK0968723T3 (da) | 1994-03-29 | 1995-03-29 | Sårheling eller helbredelse af fibrotiske lidelser ved anvendelse af mindst ét middel mod en vækstfaktor |
Country Status (12)
Country | Link |
---|---|
US (1) | US5972335A (de) |
EP (2) | EP0754058B1 (de) |
JP (1) | JP4083794B2 (de) |
AT (2) | ATE435030T1 (de) |
AU (1) | AU710153B2 (de) |
CA (1) | CA2186269C (de) |
DE (2) | DE69535976D1 (de) |
DK (2) | DK0754058T3 (de) |
ES (2) | ES2140670T3 (de) |
GR (1) | GR3032266T3 (de) |
NZ (1) | NZ282856A (de) |
WO (1) | WO1995026203A1 (de) |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9106678D0 (en) * | 1991-03-28 | 1991-05-15 | Ferguson Mark W J | Wound healing |
GB2304047A (en) | 1995-08-09 | 1997-03-12 | Univ Manchester | Pharmaceutical compositions containing cytokines |
GB9601081D0 (en) * | 1995-10-06 | 1996-03-20 | Cambridge Antibody Tech | Specific binding members for human transforming growth factor beta;materials and methods |
GB2306481A (en) | 1995-10-21 | 1997-05-07 | Univ Manchester | Pharmaceutical comprising a stimulator of activin and/or inhibin |
GB9702943D0 (en) * | 1997-02-13 | 1997-04-02 | Univ Manchester | Wound healing |
DE10022074A1 (de) * | 2000-05-06 | 2001-11-08 | Henkel Kgaa | Elektrochemisch erzeugte Schichten zum Korrosionsschutz oder als Haftgrund |
US6509318B1 (en) | 2000-09-29 | 2003-01-21 | The Regents Of The University Of California | TGF-B inhibitors and methods |
US7452454B2 (en) * | 2001-10-02 | 2008-11-18 | Henkel Kgaa | Anodized coating over aluminum and aluminum alloy coated substrates |
US7569132B2 (en) * | 2001-10-02 | 2009-08-04 | Henkel Kgaa | Process for anodically coating an aluminum substrate with ceramic oxides prior to polytetrafluoroethylene or silicone coating |
GB0217136D0 (en) * | 2002-07-24 | 2002-09-04 | Renovo Ltd | Wound healing & treatment of fibrosis |
US20050074453A1 (en) * | 2003-10-02 | 2005-04-07 | Ferree Bret A. | Methods of preventing adhesions following laminectomies and other surgical procedures |
RU2386638C2 (ru) * | 2004-03-31 | 2010-04-20 | Дженентек, Инк. | Гуманизированные анти-тфр-бета-антитела |
WO2011060079A1 (en) * | 2009-11-10 | 2011-05-19 | The Trustees Of Columbia University In The City Of New York | Compositions and methods for wound treatment |
AU2011222540B2 (en) * | 2010-03-05 | 2016-09-29 | Wake Forest University Health Sciences | Controlled delivery system |
US9700631B2 (en) | 2011-08-17 | 2017-07-11 | KeraNetics, LLC | Low protein percentage gelling compositions |
EP2744820B1 (de) | 2011-08-17 | 2018-07-25 | Keranetics LLC | Verfahren zur extraktion von keratinischen proteinen |
WO2014074532A2 (en) * | 2012-11-06 | 2014-05-15 | Scholar Rock Inc. | Compositions and methods for modulating cell signaling |
US9827245B2 (en) | 2013-03-15 | 2017-11-28 | KeraNetics, LLC | Keratin compositions comprising halofuginone |
IL301607A (en) | 2013-05-06 | 2023-05-01 | Scholar Rock Inc | Preparations and methods for growth factor modulation |
WO2017201036A1 (en) | 2016-05-17 | 2017-11-23 | Genentech, Inc. | Stromal gene signatures for diagnosis and use in immunotherapy |
MX2020004567A (es) | 2017-11-06 | 2020-08-13 | Genentech Inc | Metodos diagnosticos y terapeuticos para el cancer. |
WO2023080900A1 (en) | 2021-11-05 | 2023-05-11 | Genentech, Inc. | Methods and compositions for classifying and treating kidney cancer |
WO2024077166A1 (en) | 2022-10-05 | 2024-04-11 | Genentech, Inc. | Methods and compositions for classifying and treating lung cancer |
WO2024077095A1 (en) | 2022-10-05 | 2024-04-11 | Genentech, Inc. | Methods and compositions for classifying and treating bladder cancer |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU624789B2 (en) * | 1987-02-19 | 1992-06-25 | Amgen, Inc. | Purified platelet-derived growth factor and methods for purification thereof |
US5094941A (en) * | 1987-12-31 | 1992-03-10 | Zymogenetics, Inc. | Monoclonal antibodies to PDGF |
JPH0780780B2 (ja) * | 1989-09-29 | 1995-08-30 | ラ ホヤ キャンサー リサーチ ファウンデーション | 細胞外マトリックスの蓄積防止のためのトランスフォーミング増殖因子βの阻害 |
GB9106678D0 (en) * | 1991-03-28 | 1991-05-15 | Ferguson Mark W J | Wound healing |
DE69228700T2 (de) * | 1991-12-04 | 1999-09-09 | La Jolla Cancer Research Foundation | Verwendung von Decorin oder Biglycan zur Herstellung eines Medikaments für die Behandlung von Diabetes-bedingter Zustände |
GB9206861D0 (en) * | 1992-03-28 | 1992-05-13 | Univ Manchester | Wound healing and treatment of fibrotic disorders |
AU3943793A (en) * | 1992-04-01 | 1993-11-08 | Whittier Institute For Diabetes And Endocrinology, The | Methods of inhibiting or enhancing scar formation in the CNS |
GB9217206D0 (en) | 1992-08-13 | 1992-09-23 | Pointer John C | Photo labels |
WO1994009812A1 (en) * | 1992-10-26 | 1994-05-11 | Kirin Brewery Company, Limited | METHOD FOR PRODUCING LARGE LATENT TRANSFORMING GROWTH FACTOR-β COMPLEXES AND LARGE LATENCY ASSOCIATED PEPTIDE |
JP4350370B2 (ja) * | 2002-12-27 | 2009-10-21 | 株式会社半導体エネルギー研究所 | 電子回路及び電子機器 |
-
1995
- 1995-03-29 WO PCT/GB1995/000704 patent/WO1995026203A1/en active IP Right Grant
- 1995-03-29 ES ES95913237T patent/ES2140670T3/es not_active Expired - Lifetime
- 1995-03-29 US US08/718,492 patent/US5972335A/en not_active Expired - Fee Related
- 1995-03-29 DE DE69535976T patent/DE69535976D1/de not_active Expired - Lifetime
- 1995-03-29 EP EP95913237A patent/EP0754058B1/de not_active Expired - Lifetime
- 1995-03-29 DK DK95913237T patent/DK0754058T3/da active
- 1995-03-29 AT AT99201184T patent/ATE435030T1/de not_active IP Right Cessation
- 1995-03-29 AU AU20778/95A patent/AU710153B2/en not_active Ceased
- 1995-03-29 CA CA002186269A patent/CA2186269C/en not_active Expired - Fee Related
- 1995-03-29 NZ NZ282856A patent/NZ282856A/en not_active IP Right Cessation
- 1995-03-29 DK DK99201184T patent/DK0968723T3/da active
- 1995-03-29 DE DE69513158T patent/DE69513158T2/de not_active Expired - Lifetime
- 1995-03-29 ES ES99201184T patent/ES2329531T3/es not_active Expired - Lifetime
- 1995-03-29 AT AT95913237T patent/ATE186220T1/de not_active IP Right Cessation
- 1995-03-29 JP JP52505095A patent/JP4083794B2/ja not_active Expired - Fee Related
- 1995-03-29 EP EP99201184A patent/EP0968723B1/de not_active Expired - Lifetime
-
1999
- 1999-12-28 GR GR990403351T patent/GR3032266T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
EP0754058B1 (de) | 1999-11-03 |
ATE186220T1 (de) | 1999-11-15 |
JPH09510967A (ja) | 1997-11-04 |
DE69513158D1 (de) | 1999-12-09 |
WO1995026203A1 (en) | 1995-10-05 |
EP0968723A1 (de) | 2000-01-05 |
CA2186269C (en) | 2008-06-03 |
ATE435030T1 (de) | 2009-07-15 |
EP0754058A1 (de) | 1997-01-22 |
CA2186269A1 (en) | 1995-10-05 |
DE69513158T2 (de) | 2000-05-04 |
GR3032266T3 (en) | 2000-04-27 |
DK0968723T3 (da) | 2009-11-09 |
ES2140670T3 (es) | 2000-03-01 |
AU710153B2 (en) | 1999-09-16 |
ES2329531T3 (es) | 2009-11-26 |
EP0968723B1 (de) | 2009-07-01 |
JP4083794B2 (ja) | 2008-04-30 |
DE69535976D1 (de) | 2009-08-13 |
US5972335A (en) | 1999-10-26 |
NZ282856A (en) | 1998-06-26 |
AU2077895A (en) | 1995-10-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69513158D1 (de) | Wundheilung | |
ATE241334T1 (de) | Mittel zur förderung des haarwachstums | |
DE69910622D1 (de) | Matrixprotein enthaltende Zusammensetzungen für entzündliche und infektiöse Zustände | |
EE03741B1 (et) | N-propargüül-1-aminoindaani R-enantiomeeri, sellesoolade ja kompositsioonide kasutamine | |
DE69524682D1 (de) | Mittel zur Behandlung von Wunden | |
FI953180A0 (fi) | Sokeritaudin komplikaatioiden hoitamiseen tarkoitetut koostumukset | |
FI973828A0 (fi) | Yhdisteitä ja koostumuksia aktiivisten aineiden annostelemiseksi | |
CY1108110T1 (el) | Παραγοντες και μεθοδοι για προστασια, θεραπεια και επιδιορθωση συνδετικου ιστου | |
EP0506658A4 (en) | Compositions and method for treating painful, inflammatory or allergic disorders | |
GR3029436T3 (en) | Preparations for the external application of antiseptic agents and/or agents promoting the healing of wounds. | |
ATE235245T1 (de) | Pharmaceutische komposition | |
DK1100824T3 (da) | Forbindelser med væksthormonfrigivende egenskaber | |
DE69104656D1 (de) | Heilende Zusammensetzung zur örtlichen Anwendung. | |
WO2001030334A3 (en) | 6-methoxy-2-naphthylacetic acid prodrugs compositions for treating inflammation | |
UA15363A (uk) | Засіб для лікуваhhя відкритих пошкоджеhь |